Results 91 to 100 of about 2,919 (168)

[Low-intensity pulsed ultrasound and oridonin synergistically induce ferroptosis of pancreatic cancer cells by activating PIEZO1 <i>via</i> the Nrf2/HO-1/GPX4 pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Sun B, Guo Y, Qi Y, Yao D, Chen W, Chen N.   +5 more
europepmc   +1 more source

机器人辅助并保留脾脏的胰腺远端切除术治疗小儿实性假乳头状瘤

The use of robots in pancreatic surgery offers several advantages as an adjunct to laparoscopic surgery, including increased maneuverability of robotic instruments and three-dimensional (3D) visualization.
Byrgazov A.A., Kozlov Y.A., Makarochkina M.V., Marchuk A.A., Muravev S.A., Narkevich A.N., Poloyan S.S., Rozhanskii A.P., Sapukhin E.V., Strashinsky A.S.   +9 more
core   +1 more source

[p53-SOAT1 Axis: A Novel Target for Tumor Lipid Metabolism and Therapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Yu X, Xiao Y, Xu B, Li X, Wang H, Ren D.
europepmc   +1 more source

单克隆抗体对LAK细胞抗胰腺癌作用的影响

Zhongshan Daxue xuebao. Yixue kexue ban, 1995
本文介绍了淋巴因子活化的杀伤细胞（ＬＡＫ细胞），在ＹＰＣ３抗人胰腺癌单克隆抗体（ＹＰＣ３ｍＡｂ）的介导下，对体外、体内人胰腺癌细胞生长的影响。体外４ｈ５１Ｃｒ释放试验表明，特异性识别Ｃａｐａｎ－２人胰腺癌细胞的ＹＰＣ３ｍＡｂ能通过抗体依赖性细胞介导的细胞毒作用（ＡＤＣＣ）显著增强ＬＡＫ细胞对Ｃａｐａｎ－２细胞的杀伤作用，这种作用随ｍＡｂ的浓度增加而加强，５０μｇ／ｍｌ的ＹＰＣ３ｍＡｂ提高ＬＡＫ细胞杀伤率约６０％。对照ｍＡｂ无此作用。裸鼠体内实验发现，ＹＰＣ３ｍＡｂ与ＬＡＫ细胞联合应用能完全阻止Ｃａｐａｎ－
doaj  

[Recent Advances in the Interorgan Regulatory Roles of Adipose Tissue]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li Z, Xu C, Xu R, Zhou C, Fan Y.
europepmc   +1 more source

趋化素样因子超家族成员在胰腺癌中的表达和临床意义

Zhongguo shiyan zhenduanxue
目的应用生物信息学的方法探讨趋化素样因子超家族成员（chemokine-like factor-like MARVEL transmembrane domain containing member/chemokine-like factor superfamily member,CMTM/CKLFSF，CMTM）在胰腺癌中异常表达的临床病理特征,并分析相关基因共表达的意义。方法通过GEPIA2、HPA和Kaplan-Meier plotter数据库分析CMTM家族成员在胰腺癌中的表达和预后价值 ...
黄冠宁, 张茗然, 王绪凯, 王福昊, 黄金正, 刘光耀   +5 more
doaj   +2 more sources

胰腺癌的肿瘤标志物

Zhongguo shiyan zhenduanxue, 1997
胰腺癌的肿瘤标志物张太平赵玉沛作者单位：１００７３０北京，中国医学科学院北京协和医院外科胰腺癌发病率近年来在全球呈上升趋势，总的五年生存率仅３％。改善胰腺癌患者生存状况的关键是提高早期诊断水平，研究更加有效的筛选技术。虽然近年来影像学诊断有了较大进展...
doaj  

[High expression of MPP6 predicts poor patient prognosis and promotes malignant biological behaviors of hepatocellular carcinoma cells]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yu H, Shao Y, Cheng Q, Zhou X, Geng H, Yang Y.   +5 more
europepmc   +1 more source

[Primary hepatic neuroendocrine neoplasms: a case series analysis of 10 patients and literature review]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Jiang Y, Meng Y, Zhang S, Wang Y, Wang C, Lu C.   +5 more
europepmc   +1 more source

[Advances in Surgical Treatment Following Conversion Therapy for Pancreatic Cancer]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Meng L, Li Y, Peng B.
europepmc   +1 more source